- Home
- PPSI vs NTRB Comparison
PPSI vs NTRB Comparison
Compare PPSI & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPSI | NTRB |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.4M | 57.0M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | PPSI | NTRB |
|---|---|---|
| Price | $3.82 | $4.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 126.2K | 11.6K |
| Earning Date | 02-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1626.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,879,000.00 | N/A |
| Revenue This Year | $26.84 | $30.17 |
| Revenue Next Year | $10.26 | $3,394.36 |
| P/E Ratio | $1.34 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.26 | $3.96 |
| 52 Week High | $5.70 | $11.68 |
Technical Indicators
Market Signals| Indicator | PPSI | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 41.85 | 43.74 |
| Support Level | $3.79 | $3.96 |
| Resistance Level | $4.48 | $4.35 |
| Average True Range (ATR) | 0.35 | 0.25 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 17.58 | 23.74 |
Price Performance
Historical ComparisonAbout PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.